Abstract:Objective: Previous studies have reported low incidence of carboplatin-related drug fever in early cancer treatment cycles. This study describes and analyzes relatively higher incidence rate of carboplatinrelated drug fever associated with gynecologic cancer chemotherapy in order to allay anxiety in patients and avoid unnecessary interventions. Materials and methods: All gynecologic cancer cases treated with carboplatin in a women's hospital in 2017 and 2018 were retrospectively reviewed and analyzed. Data for patients who experienced carboplatin-induced drug fever and those who received the same treatment but did not experience drug fever were compared for statistical significance. Risk factors for drug fever were identified by logistic regression analysis. Results: In total, 318 females with a mean age of 52 years were included in the analysis. Drug fever was observed in 25 patients (7.86%) in 45 cycles of total 1605 carboplatin-containing infusions. Fever occurred at a median of the third (range: 1-7) cycle, starting at 10.62 h (range: 1.18-50.35 h) after carboplatin infusion, and was generally controlled within 3 days. After chemotherapy rechallenge, the mean frequency of drug fever was 2 times per patient (range: 1-4 times). There were 35/45 drug fever incidents (77.78%) that were classified as grade II; in 15/45 cases (33.33%), antibiotic treatment was immediately initiated to prevent infection. Younger age was found to be a risk factor for drug fever following carboplatin treatment (odds ratio 1/4 0.126, 95% confidence interval: 0.025-0.628; p < 0.05). Conclusions: The retrospective analysis demonstrated that carboplatin-induced drug fever, which occurred on post treatment 3 days, was a type of delayed hypersensitivity reaction with an incidence rate of 7.86% in gynecologic cancer. Younger age was identified as a risk factor. Drug fever is generally tolerated by patients, who insist on chemotherapy. Knowledge of carboplatin-induced drug fever may help physicians reach timely recognition for appropriate interventions. (c) 2021 Taiwan Association of Obstetrics & Gynecology. Publishing services by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Endocrine Fever

Diabetes Fever

Drug Fever Induced by Carboplatin-Based Regimens: Higher Incidence in a Women's Hospital.

Role of Fever in Disease

Fever: Causes and consequences

Severe ischemic-type biliary strictures due to hepatic artery occlusion seven years after liver transplantation--a rare cause of late cholestatic graft failure.

Angioplasty of the Innominate Artery in 89 Patients: Experience over 19 Years

Sex and genetic differences in hair color changes during early childhood.

Fever and the thermal regulation of immunity: the immune system feels the heat

New Concepts on the Pathogenesis of Fever

Stimulation of adenosine 3,5-monophosphate formation in mast cells by 5-hydroxytryptamine and guanethidine.

Usefulness and problems of endoscopic ultrasonography in prediction of the depth of tumor invasion in early gastric cancer.

Inositol-Requiring Enzyme 1 Pathway and Autophagy Drive Sequential Response of Endothelial Cells to Febrile Range Hyperthermia

Global Warming and Endocrinology: The Hyderabad Declaration of the South Asian Federation of Endocrine Societies

Fever and immunoregulation. III. Hyperthermia augments the primary in vitro humoral immune response

Fever As the Exclusive Presenting Symptom in a Case of Colon Cancer

Short-term load forecasting of Toronto Canada by using different ANN algorithms

Fever As a First Manifestation of Advanced Gastric Adenosquamous Carcinoma: a Case Report.

Fever: Role of Pyrogens and Cryogens

Addressing Health Challenges: Family Support and Management Strategies for Chronic Endogenous Infections in Children with Hyperthermia

Approach to fever in children